1 Min Read
Sept 1 (Reuters) - REDWOOD PHARMA AB:
* ENTERS INTO AGREEMENT WITH CRO FOR CLINICAL PHASE II TRIAL Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.